Login / Signup
Kepeng Che
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 2
Top Topics
Cell Cycle
Randomized Controlled Trial
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ajaybabu V Pobbati
,
Ashley Burtscher
,
Nandini Rajaram Siva
,
Andrea Hallett
,
Todd Romigh
,
Kepeng Che
,
Bin Zhao
,
Jesse A Coker
,
Nancy Wang
,
Shaun R Stauffer
,
Brian P Rubin
CDK9 inhibition by dinaciclib is a therapeutic vulnerability in epithelioid hemangioendothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Caleb N Seavey
,
Andrea Hallett
,
Shuo Li
,
Kepeng Che
,
Ajaybabu V Pobbati
,
Shuang Ma
,
Ashley Burtscher
,
Ryan Kanai
,
Janine S A Warren
,
Brian P Rubin
Loss of CDKN2A cooperates with WWTR1(TAZ)-CAMTA1 gene fusion to promote tumor progression in epithelioid hemangioendothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)